Ethics and efficiency in vaccine distribution

This contribution was delivered online on 6 May 2021 on the occasion of the hybrid 2021 edition of EUI State of the Union on ‘Europe in a Changing World'.This panel will address two key problems underpinning the ethics and efficacy of the distribution of the COVID-19 vaccine. First, the key assumptions that guide the ethics of vaccine distribution remain uncertain, such as whether the vaccines stop transmission or only prevent severe illness. Second, the most efficacious methods for distribution may conflict with both ethical guidelines and public sentiment. Ethical discussions have revolved around protecting the vulnerable, while public opinion often is based on ideas about ‘deservingness.’ But neither perspective may actually be the best guide for actually stopping the pandemic. This panel will discuss scientific findings based on simulation models of vaccine distribution, public opinion surveys, and comparative policy analysis of vaccine distribution